Subscribe to Newsletter

Retina

Business & Profession Retina

Responding to Short-Sightedness

| Mark A. Bullimore | 4 min read

An open letter to The Ophthalmologist
Subspecialties Retina

Retinal Flow

| Alun Evans | 2 min read

Innovative technique for predicting chronic cerebral hypoperfusion
Subspecialties Retina

A Vision for the Future

| Oscelle Boye | 7 min read

Sitting Down With… Sascha Fauser, Global Head of Ophthalmology, Pharma Research and Early Development (pRED) Vice President, Roche
Subspecialties Glaucoma

The Mindset Shift

| 3 min read

If the drop first regimen isn’t working – what comes next?
Business & Profession Retina

Following New Pathways

| Alun Evans | 6 min read

The biotech company taking anti-VEGF therapies to the next level
Subspecialties Retina

Perceiving the Algorithm

| Alun Evans | 2 min read

How do retinal disease patients perceive AI-driven technology?
Subspecialties Retina

Stopping The Unstoppable

| Sarah Healey | 6 min read

FDA approve new treatment for geographic atrophy
Subspecialties Retina

Introducing: The Ophthalmologist Power List Hall of Fame

| Oscelle Boye | 2 min read

Subspecialties Retina

It’s About Time

| Sarah Healey | 2 min read

A new retinal aging clock set to provide clearer diagnoses and develop understandings of the aging process
Subspecialties Retina

In It for the Long Haul

| Sarah Healey | 4 min read

Data suggests that the highest concentration of atropine is highly effective at slowing myopia progression
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

February Issue of The Ophthalmologist
Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: